Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B‐cel...
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B‐cell lymphoma
About this item
Full title
Author / Creator
Izutsu, Koji , Kumode, Takahiro , Yuda, Junichiro , Nagai, Hirokazu , Mishima, Yuko , Suehiro, Youko , Yamamoto, Kazuhito , Fujisaki, Tomoaki , Ishitsuka, Kenji , Ishizawa, Kenichi , Ikezoe, Takayuki , Nishikori, Momoko , Akahane, Daigo , Fujita, Jiro , Dinh, Minh , Soong, David , Noguchi, Hidehisa , Buchbjerg, Jeppe Klint , Favaro, Elena and Fukuhara, Noriko
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Epcoritamab is a subcutaneously administered CD3xCD20 bispecific Ab that showed deep, durable responses with a manageable safety profile in patients with relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) in the global multicenter pivotal phase II trial EPCORE NHL‐1. Here, we present results from the similar EPCORE NHL‐3 phase I/II...
Alternative Titles
Full title
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B‐cell lymphoma
Authors, Artists and Contributors
Author / Creator
Kumode, Takahiro
Yuda, Junichiro
Nagai, Hirokazu
Mishima, Yuko
Suehiro, Youko
Yamamoto, Kazuhito
Fujisaki, Tomoaki
Ishitsuka, Kenji
Ishizawa, Kenichi
Ikezoe, Takayuki
Nishikori, Momoko
Akahane, Daigo
Fujita, Jiro
Dinh, Minh
Soong, David
Noguchi, Hidehisa
Buchbjerg, Jeppe Klint
Favaro, Elena
Fukuhara, Noriko
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10728012
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10728012
Other Identifiers
ISSN
1347-9032,1349-7006
E-ISSN
1349-7006
DOI
10.1111/cas.15996
